. Reference: Klette, T.J., and S. Kortum (2002) “Innovating Firms and Aggregate Innovation,” NBER Working Paper 8819. …

?s main objective is to assess the contribution of pharmaceutical innovation to the increase in cancer survival rates. Only … these differential rates of progress were partly attributable to different rates of pharmaceutical innovation for different … of pharmaceutical innovation to longevity increase I obtained in an earlier study, although that study was based on a …

search suggests that a low search cost can turn out to have detrimental incentives on innovation and new product introduction … as the low search cost erodes firms' market power, attenuating the profit from innovation. This usual model, however … search cost. In this environment, a low search cost could turn out to be favorable to innovation. At a low search cost …